3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
15
Tumor-Agnostic
13
Thoracic
10
Lymphoid
8
Gynecologic
8
Head & Neck
6
CNS
6
Dermatologic
5
Breast
5
Sarcoma
4
Other hematologic neoplasm
4
Genitourinary
4
Plasma cell
3
Other solid neoplasm
2
Myeloid
2
Endocrine
2
Other
1
NET
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Unknown Primary
1
Interventions
Everolimus
5
Sunitinib
4
lutetium Lu 177 dotatate
2
PM 01183
2
Octreotide
2
Doxorubicin
2
trifluridine tipiracil drug combination
1
telotristat ethyl
1
repotrectinib
1
pralsetinib
1
pegfilgrastim
1
pasireotide
1
motesanib diphosphate
1
epothilone B
1
dactolisib
1
copper dotatate CU-64
1
batifiban
1
avelumab
1
alectinib
1
Temozolomide
1
TKM-080301
1
Surveys and Questionnaires
1
SNX-5422
1
Referral and Consultation
1
Radiomics
1
Quality of Life
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
Molecular Diagnostic Techniques
1
Lutetium-177
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Drug Therapy
×
NET
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled